Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
Both inflammation and smoking can influence a drug’s pharmacokinetic properties, i.e., its liberation, absorption, distribution, metabolism, and elimination. Depending on, e.g., pharmacogenetics, these changes may alter treatment response or cause serious adverse drug reactions and are thus of clini...
Main Authors: | Nicole Moschny, Gudrun Hefner, Renate Grohmann, Gabriel Eckermann, Hannah B Maier, Johanna Seifert, Johannes Heck, Flverly Francis, Stefan Bleich, Sermin Toto, Catharina Meissner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/6/514 |
Similar Items
-
Application of Antipsychotic Drugs in Mood Disorders
by: Janusz K. Rybakowski
Published: (2023-02-01) -
Computer-aided drug design and in silico pharmacokinetics predictions of some potential antipsychotic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2021-07-01) -
The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer’s Disease
by: Maria Podsiedlik, et al.
Published: (2022-04-01) -
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
by: Michele Persico, et al.
Published: (2022-01-01) -
NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality
by: Marek Krzystanek, et al.
Published: (2019-03-01)